Norio Komatsu

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 311 publications

Cross-study analyses of the ropeginterferon alfa-2b effect on phlebotomy in low- and high-risk patients with polycythemia vera.

Cross-study analyses of the ropeginterferon alfa-2b effect on phlebotomy in low- and high-risk patients with polycythemia vera.

Journal: Leukemia & lymphoma

Published: July 17, 2026

Hepatic leukemia factor directs tissue residency of proinflammatory memory CD4+ T cells.

Hepatic leukemia factor directs tissue residency of proinflammatory memory CD4+ T cells.

Journal: Science (New York, N.Y.)

Published: December 11, 2025

Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis.

Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis.

Journal: International journal of hematology

Published: October 02, 2025

Efficacy and safety of a three-step dose escalation regimen of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: a phase 3b, single-arm, multicenter study.

Efficacy and safety of a three-step dose escalation regimen of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: a phase 3b, single-arm, multicenter study.

Journal: International journal of hematology

Published: August 25, 2025

Effect of food on iron absorption in patients with iron deficiency anemia treated with ferric citrate hydrate.

Effect of food on iron absorption in patients with iron deficiency anemia treated with ferric citrate hydrate.

Journal: International journal of hematology

Published: August 12, 2025

Cost-effectiveness analysis of ropeginterferon alfa-2b for the management of patients with polycythemia vera in Japan.

Cost-effectiveness analysis of ropeginterferon alfa-2b for the management of patients with polycythemia vera in Japan.

Journal: International journal of hematology

Published: July 22, 2025

Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study.

Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study.

Journal: The Lancet. Haematology

Published: June 11, 2025

Correction: Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera.

Correction: Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera.

Journal: International journal of hematology

Published: May 16, 2025

Loss of KDEL function from a calreticulin frameshift mutation drives expression of an immature, mutant calreticulin-dependent form of the thrombopoietin receptor MPL.

Loss of KDEL function from a calreticulin frameshift mutation drives expression of an immature, mutant calreticulin-dependent form of the thrombopoietin receptor MPL.

Journal: Haematologica

Published: February 12, 2025

Ropeginterferon-α2b discontinuation after long-term exposure: four cases from a single institution.

Ropeginterferon-α2b discontinuation after long-term exposure: four cases from a single institution.

Journal: International journal of hematology

Published: January 29, 2025

Post-Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential Thrombocythemia.

Post-Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential Thrombocythemia.

Journal: EJHaem

Published: January 19, 2025

A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera.

A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera.

Journal: Hematology (Amsterdam, Netherlands)

Published: November 15, 2024

Showing 1-12 of 311

Last Updated: 09/26/2026